The University of Edinburgh
Tackling the fundamentals of viral epidemiology and vaccine development using genomics and data science techniques
Abstract
dc:description.abstractThe Herpesviridae family includes eight viruses routinely capable of infecting humans, two of which - Epstein-Barr virus (EBV) and Cytomegalovirus (CMV) - are the focus of this research. EBV is highly prevalent, infecting 90–95% of individuals worldwide. While typically asymptomatic when acquired in childhood, infection during adolescence can result in infectious mononucleosis (glandular fever). Additionally, EBV has been associated with certain malignancies and has been increasingly implicated as a potential contributor to multiple sclerosis (MS). CMV infects approximately 40–60% of the population and represents a major cause of congenital disabilities and developmental delays in neonates. Once acquired, both viruses establish lifelong latency within the host. Given their association with severe health complications, substantial efforts have been made to develop vaccines for both EBV and CMV. However, no effective vaccine candidates have been developed to date, although several remain under investigation. The limited understanding of both modifiable (e.g. smoking status) and non-modifiable (e.g. age) factors association with EBV or CMV acquisition is a key barrier to preventing these infections. Understanding these factors are useful for policymakers for the stratification and prioritisation of a population when implementing a future vaccine candidate. Previous research on genetic and sociodemographic risk factors have been inconclusive, particularly for CMV, for which no large-scale genetic susceptibility studies have been conducted. This thesis aimed to investigate genetic and environmental factors influencing acquisition of EBV and CMV using data from the UK Biobank, a large-scale population-based study comprising 500,000 individuals. Serological data were available for approximately 10,000 participants who underwent antibody testing for EBV and CMV, enabling genetic association analyses. Through genome-wide association studies (GWAS), two novel loci associated with EBV serostatus were identified. However, there were no significant findings for CMV; thus, EBV became the focus of the remaining analyses. Mendelian randomisation analyses confirmed that lower educational attainment, and earlier age of smoking initiation are determinants of EBV serostatus. The systematic literature review documented the age of acquisition across various socioeconomic and geographic contexts. At the same time, the meta-analysis revealed that younger age groups in middle-income countries exhibited higher seroprevalence compared to those in high-income countries. Suggesting that country income level is a useful factor to consider when deciding when to vaccinate in these countries. Given the growing interest in and potential for an EBV vaccine, understanding the modifiable and non-modifiable factors influencing susceptibility and the age of acquisition is critical for informing vaccine deployment strategies. Identifying these factors allows for the targeted immunisation of individuals at the highest risk of acquiring EBV and CMV, providing insights into the optimal age for vaccination and the prioritisation of specific populations when a vaccine becomes available.
Degree
thesis:*- Grantor dc:publisher
- The University of Edinburgh
- Year dc:date.issued
- 2025
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Muckian, Marisa D.
- Advisors dc:contributor.advisor
-
- Stagg, Helen
- Pirastu, Nicola
- Wilson, Jim
Subjects
dc:subject × 5Rights
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Identifier URI
- http://dx.doi.org/10.7488/era/6364